MariMed Inc. (MRMD) Financials

MRMD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 197.2 million 147.1 million
March 31, 2026 201.2 million 154.7 million
Dec. 31, 2025 202.6 million 152.6 million
Sept. 30, 2025 205.6 million 151.3 million

MRMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 1.9 million 350000
March 31, 2026 576000 325000
Dec. 31, 2025 3.4 million 382000
Sept. 30, 2025 2.4 million 382000

MRMD Net Income

No data available :(

MRMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 8.4 million 82.3 million 11.9 million
March 31, 2026 7.9 million 76.0 million 11.9 million
Dec. 31, 2025 8.9 million 84.9 million 12.6 million
Sept. 30, 2025 6.6 million 92.4 million 13.2 million

MRMD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 ?
Dec. 31, 2025 ?
Sept. 30, 2025 ?

MRMD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 298000 - 7.7 million 847000
March 31, 2026 373000 - 7.7 million 765000
Dec. 31, 2025 33000 - 761000 1.2 million
Sept. 30, 2025 314000 - 7.7 million 1.1 million

MRMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 41.9 million 25.7 million
March 31, 2026 39.5 million 24.2 million
Dec. 31, 2025 41.7 million 31.1 million
Sept. 30, 2025 40.8 million 24.4 million

MRMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRMD

Price: $0.06

52 week price:
0.06
0.18

Payout Ratio Range:
-743.67%
865.15%

Earnings Per Share: -0.05 USD

P/E Ratio: -1.68

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 278400

Market Capitalization: 27.5 million

Links: